- Home
- CRIS vs COSM Comparison
CRIS vs COSM Comparison
Compare CRIS & COSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CRIS | COSM |
|---|---|---|
| Founded | 2000 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Other Pharmaceuticals |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.0M | 15.8M |
| IPO Year | 2000 | 2009 |
Fundamental Metrics
Financial Performance| Metric | CRIS | COSM |
|---|---|---|
| Price | $0.50 | $0.25 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $17.00 | N/A |
| AVG Volume (30 Days) | 255.2K | ★ 705.9K |
| Earning Date | 05-07-2026 | 04-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 91.57 | 46.15 |
| EPS | N/A | ★ N/A |
| Revenue | $9,898,000.00 | ★ $65,271,815.00 |
| Revenue This Year | $27.10 | $54.08 |
| Revenue Next Year | $67.74 | $32.66 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 31.50 | 19.93 |
| 52 Week Low | $0.46 | $0.25 |
| 52 Week High | $3.13 | $1.32 |
Technical Indicators
Market Signals| Indicator | CRIS | COSM |
|---|---|---|
| Relative Strength Index (RSI) | 39.88 | 25.64 |
| Support Level | $0.49 | N/A |
| Resistance Level | $0.63 | $0.41 |
| Average True Range (ATR) | 0.04 | 0.02 |
| MACD | -0.00 | -0.01 |
| Stochastic Oscillator | 24.80 | 6.18 |
Price Performance
Historical ComparisonAbout CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
About COSM Cosmos Health Inc.
Cosmos Health Inc is a diversified, vertically integrated healthcare group, owner of proprietary pharmaceutical and nutraceutical brands, generics, manufacturer and distributor of healthcare products, engaged in research & development of medicines and repurposing drugs as well as operator of a telehealth platform. The company has developed its own proprietary branded nutraceutical products, named 'Sky Premium Life' and 'Mediterranation'. Its product portfolio includes generics and over-the-counter pharmaceutical products, medicines, as well as nutraceuticals and biocides. The company's Reportable segments are Wholesale, Pharma manufacturing, and Nutraceutical and pharmaceuticals, with the majority of revenue generated from the Wholesale segment.